A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
The Federal Circuit upheld a $31 million win for Energy Transportation Group on Friday in a suit against William Demant Holding A/S and Widex A/S over two patents related to reducing feedback in digital hearing aids, rejecting the defendants’ bid to reduce the damages award. Law360